Our Vision

Welcome to ESI BIO, providing stem cell researchers with products and technologies that will assist them in translating their work into the clinic.

Advances in the basic science of stem cell biology have been astounding, yet the success in translating these discoveries into the clinic has lagged behind, partly because of a lack of basic research tools that can meet the regulatory requirements for clinical grade manufacturing and medical use. The people at ESI BIO are dedicated to solving this problem.

ESI BIO has a proud heritage of creating clinical grade stem cell products, being the first to produce clinical-grade human embryonic stem cells and publish the results in 2007. Through our position as a member of the family of stem-cell-based subsidiary companies owned by BioTime, Inc., we have access to an incredibly strong team of scientists experienced in the use of pluripotent stem cells in clinical trials, and we have access to the largest portfolio of intellectual property in the field. Our people are our strongest asset, and we are assembling product development and marketing teams that will expand our current family of stem cell products, including our family of pluripotent and progenitor stem cells and hydrogel matrix products.

Keep your eye on ESI BIO, we have great things planned in the form of products to help our research customers accelerate their discoveries into medical applications. Our vision is to realize the promise of stem cell science to relieve the suffering caused by many intractable degenerative diseases.

So as you explore ESI BIO, we hope you begin to get excited about the way we believe we are providing value for our customers and building a great place to work for our people. And you don't have to wait to get started, please join one of our social communities (Facebook,Twitter, LinkedIn) and begin to build a relationship with ESI BIO. We look forward to building one with you.

Sincerely,
Jeffrey Janus
VP Sales & Marketing